Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-22-012919

President, Ophthalmology & CMO acquired 63,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goldstein Michael H. · President, Ophthalmology & CMO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-03 Grant or award : show line 1 in the form +63,333 313,335 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +190,000 190,000 D
Loading xslF345X03/tm225652-2_4seq1.xml…